Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | KRW 37.63T | 193.1x | -2.65 | KRW 178,300 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.4% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 4.46T | -1,200.5x | -16.23 | KRW 122,100 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.7% Upside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 2.41T | KRW 29,500 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 2.31T | -108.9x | 16.31 | KRW 94,100 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.83T | -29.4x | 0.07 | KRW 38,200 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12% Upside | Upgrade to Pro+ | |
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.69T | -35.3x | 5.46 | KRW 101,100 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.11T | 37.6x | 0.03 | KRW 23,950 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 504.19B | KRW 11,450 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 454.26B | -18.2x | 0.03 | KRW 17,730 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 419.83B | -42.3x | -10.73 | KRW 17,630 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 399.71B | KRW 28,600 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 357.17B | KRW 16,110 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 352.15B | -10.9x | 1.57 | KRW 2,565 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 345.42B | -42.6x | 0.04 | KRW 10,450 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 328.41B | -6.8x | 0.03 | KRW 38,800 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 312.52B | -13.2x | 0.58 | KRW 18,850 | 11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 310.99B | -25.1x | -1.52 | KRW 19,250 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellivery | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 248.38B | -0.44 | KRW 6,680 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 233.76B | -0.45 | KRW 2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 230.85B | -25x | -25.77 | KRW 10,100 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 209.96B | -4.1x | -0.28 | KRW 4,095 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 206.48B | -4.3x | -0.07 | KRW 4,620 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 195.33B | -35.1x | 0.17 | KRW 2,285 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 193.91B | KRW 6,220 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 193.59B | -3.4x | 0.1 | KRW 6,770 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 193.5B | -5.1x | -0.7 | KRW 3,525 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 191.4B | -7.5x | 0.18 | KRW 7,200 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 191.1B | KRW 18,250 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 184.21B | -39.5x | -0.78 | KRW 5,640 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orientbio | Seoul | Healthcare | Biotechnology & Medical Research | KRW 182.12B | -19.7x | KRW 1,451 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 172.74B | 31.1x | 0.07 | KRW 2,020 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | KRW 171.23B | -2.3x | 0.07 | KRW 2,125 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 168.3B | KRW 15,670 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 157.67B | -7.7x | -3.16 | KRW 15,980 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 151.58B | KRW 14,330 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Panagene | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 127.83B | -10.9x | KRW 3,060 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 126.5B | KRW 17,560 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 126.47B | -4.7x | -0.1 | KRW 9,780 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 118.04B | -9.1x | 0.17 | KRW 5,460 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 117.39B | -6.3x | -0.13 | KRW 3,475 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noul | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 116.2B | -5x | -0.3 | KRW 3,165 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OnCoCross | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 115.02B | 1.92 | KRW 10,060 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kang Stem Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 110.59B | -11.6x | -0.15 | KRW 2,030 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharos IBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 105.9B | -9.6x | 4.68 | KRW 8,480 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cytogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 103.7B | -6.6x | -0.35 | KRW 4,405 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shaperon | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 103.09B | -5.2x | 0.27 | KRW 3,435 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellid | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 102.98B | -8.1x | -0.2 | KRW 5,000 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ADM Korea | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 102.74B | -3.9x | 0.01 | KRW 2,500 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cell Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 97.53B | 8.9x | 0 | KRW 14,050 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curacle Co | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 94.2B | -5.3x | 0.1 | KRW 6,980 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |